Name: Name:5-Aminoisoquinoline
Brand: AABLOCKS
SKU: AA003MBI
Rating: 90 (10 reviews)

Catalog No.: AA003MBI

1125-60-6 | 5-Aminoisoquinoline

Pack Size： 1g

Purity： 98%

in stock

$7.00 $5.00

Pack Size： 5g

Purity： 95%

in stock

$9.00 $7.00

Pack Size： 10g

Purity： 95%

in stock

$15.00 $10.00

Pack Size： 25g

Purity： 95%

in stock

$29.00 $20.00

Quantity

- +

Add to Card

Order Now

bulk Quotation Request

Technical Information

Catalog Number: AA003MBI

Chemical Name: 5-Aminoisoquinoline

CAS Number: 1125-60-6

Molecular Formula: C9H8N2

Molecular Weight: 144.1732

MDL Number: MFCD00006907

SMILES: Nc1cccc2c1ccnc2

NSC Number: 46880

Properties

BP: 335.7 °C at 760 mmHg

Form: Solid

MP: 125-128 °C

Refractive Index: 1.7080 (estimate)

Stability: Light Sensitive

Storage: Keep in dry area;Room Temperature;

Complexity: 136

Covalently-Bonded Unit Count: 1

Defined Atom Stereocenter Count: 0

Defined Bond Stereocenter Count: 0

Formal Charge: 0

Heavy Atom Count: 11

Hydrogen Bond Acceptor Count: 2

Hydrogen Bond Donor Count: 1

Isotope Atom Count: 0

Rotatable Bond Count: 0

Undefined Atom Stereocenter Count: 0

Undefined Bond Stereocenter Count: 0

XLogP3: 1.4

Upstream Synthesis Route

1125-60-6

2439-04-5

[1]JournalfuerPraktischeChemie(Leipzig),1895,vol.<2>52,p.10

[2]JournalfuerPraktischeChemie(Leipzig),1895,vol.<2>52,p.10

[3]YakugakuZasshi,1953,vol.73,p.666

[4]Chem.Abstr.,1954,p.7014

1125-60-6

23687-27-6

[1]JournalofMedicinalChemistry,2002,vol.45,#3,p.740-743

[2]Patent:WO2009/130481,2009,A1,

1125-60-6

5430-45-5

[1]JournalofMedicinalChemistry,2005,vol.48,#15,p.4972-4982

1125-60-6

34784-04-8

[1]CanadianJournalofChemistry,2005,vol.83,#3,p.213-219

[2]Patent:WO2009/130481,2009,A1,.Locationinpatent:Page/Pagecolumn142

[3]Patent:US2003/199511,2003,A1,.Locationinpatent:Page/Pagecolumn34

[4]Patent:WO2003/76398,2003,A2,.Locationinpatent:Page/Pagecolumn27

[5]Patent:US2004/180874,2004,A1,.Locationinpatent:Page/Pagecolumn18-19

[6]Patent:WO2003/76442,2003,A1,.Locationinpatent:Page/Pagecolumn40

[7]Patent:US2003/187026,2003,A1,

1125-60-6

12775-96-1

34784-04-8

[1]Patent:US2003/83352,2003,A1,

[2]Patent:US2002/119963,2002,A1,

Downstream Synthesis Route

374554-54-8

1125-60-6

[1]JournaloftheAmericanChemicalSociety,1947,vol.69,p.1939,1941

607-32-9

1125-60-6

[1]Synlett,1998,p.1028-1028

[2]Patent:CN105906564,2016,A.Locationinpatent:Page/Pagecolumn9;24;25

[3]JournaloftheChemicalSociety.PerkinTransactions1(2001),2001,p.955-977

[4]ARKIVOC,2010,vol.2010,p.265-290

[5]JournalofHeterocyclicChemistry,2012,vol.49,p.1443-1446

[6]BioorganicandMedicinalChemistry,2008,vol.16,p.4617-4625

[7]TurkishJournalofChemistry,2017,vol.41,p.784-792

[8]CatalysisCommunications,2015,vol.67,p.64-67

[9]Chemicalandpharmaceuticalbulletin,1980,vol.28,p.2515-2518

[10]CatalysisLetters,2014,vol.144,p.1258-1267

[11]ChemistryofHeterocyclicCompounds,1984,vol.20,p.394-398 KhimiyaGeterotsiklicheskikhSoedinenii,1984,vol.20,p.490-494

[12]JournalofOrganicChemistry,2014,vol.79,p.9433-9439

[13]AppliedOrganometallicChemistry,2020

[14]Chemistry-AEuropeanJournal,2018,vol.24,p.8989-8993

[15]JournalofMedicinalChemistry,2005,vol.48,p.4972-4982

[16]ChemCatChem,2019,vol.11,p.4189-4195

[17]Steroids,1995,vol.60,p.693-698

[18]NewJournalofChemistry,2018,vol.42,p.1373-1378

[19]JournalofChemicalResearch-PartS,2000,p.290-291

[20]TetrahedronLetters,2012,vol.53,p.4858-4861

[21]JournalofOrganicChemistry,1986,vol.51,p.2011-2021

[22]Tetrahedron,2018,vol.74,p.2121-2129

[23]Tetrahedron,2017,vol.73,p.3898-3904

[24]SyntheticCommunications,2000,vol.30,p.3745-3754

[25]Patent:WO2012/146724,2012,A2.Locationinpatent:Page/Pagecolumn49

[26]Patent:US2014/57942,2014,A1.Locationinpatent:Paragraph0339

[27]Patent:WO2014/68035,2014,A1.Locationinpatent:Page/Pagecolumn35

[28]OrganicLetters,2019,vol.21,p.3764-3768

[29]JournalfurpraktischeChemie(Leipzig1954),1893,vol.<2>47,p.253

[30]JournalofOrganicChemistry,1945,vol.10,p.347,356

[31]JournaloftheChemicalSociety,1946,p.958,962

[32]MonatsheftefurChemie,1893,vol.14,p.146

[33]BioorganicandMedicinalChemistryLetters,1996,vol.6,p.2623-2628

[34]Patent:US2003/114422,2003,A1

[35]IndianJournalofChemistry-SectionBOrganicandMedicinalChemistry,2014,vol.53,p.1098-1109

[36]AngewandteChemie-InternationalEdition,2016,vol.55,p.15175-15179 Angew.Chem.,2016,vol.128,p.15400-15404,5

[37]BioorganicChemistry,2019,vol.82,p.100-108

[38]Patent:US4022900,1977,A

1125-60-6

90564-61-7

[1]CurrentPatentAssignee:JOHNSON&JOHNSONINC-US2018/170909,2018,A1Locationinpatent:Paragraph1355;1356

[2]Locationinpatent:experimentalpartFathalipour,Soghra;Shahrokhnia,Nazila;Afghan,Arash;Baradarani,MehdiM.[AsianJournalofChemistry,2010,vol.22,#8,p.5808-5814]

[3]Ferlin;Chiarelotto;Basadonna;Gia;Mobilio;Baccichetti;Carlassare[IlFarmaco,1989,vol.44,#12,p.1141-1155]

[4]CurrentPatentAssignee:CHEMOCENTRYXINC-US2013/225580,2013,A1Locationinpatent:Paragraph0198;0199

[5]CurrentPatentAssignee:CHEMOCENTRYXINC-US2018/9797,2018,A1Locationinpatent:Paragraph0195;0196

1125-60-6

43101-10-6

[1]CurrentPatentAssignee:RHEOSMEDICINESINC-WO2021/138298,2021,A1Locationinpatent:Paragraph00120;00178

[2]Peng,Xin;Wang,Qi;Mishra,Yogesh;Xu,Jinbin;Reichert,DavidE.;Malik,Maninder;Taylor,Michelle;Luedtke,RobertR.;Mach,RobertH.[BioorganicandMedicinalChemistryLetters,2015,vol.25,#3,p.519-523]

[3]Hollywood,Frank;Nay,Barry;Scriven,EricF.V.;Suschitzky,Hans;Khan,ZafarU.;Hull,Roy[JournaloftheChemicalSociety.PerkintransactionsI,1982,p.421-429]

[4]Li,Jinyu;Nie,Cunbin;Qiao,Yue;Hu,Jing;Li,Qifei;Wang,Qiang;Pu,Xiaohui;Yan,Lin;Qian,Hai[EuropeanJournalofMedicinalChemistry,2019,vol.178,p.433-445]

1125-60-6

90721-34-9

[1]Patent:US2003/158188,2003,A1

[2]Patent:US6933311,2005,B2

[3]Patent:US2005/113576,2005,A1.Locationinpatent:Page/Pagecolumn34

[4]Patent:US2004/157849,2004,A1

Literature fold

Title: Isoquinolin-5-amine.

Journal: Acta crystallographica. Section C, Crystal structure communications20121001

Title: Rapid alterations of cell cycle control proteins in human T lymphocytes in microgravity.

Journal: Cell communication and signaling : CCS20120101

Title: Inhibition of poly(ADP-ribose) polymerase-1 attenuates the toxicity of carbon tetrachloride.

Journal: Journal of enzyme inhibition and medicinal chemistry20111201

Title: Oocyte numbers in the mouse increase after treatment with 5-aminoisoquinolinone: a potent inhibitor of poly(ADP-ribosyl)ation.

Journal: Biology of reproduction20100501

Title: Evaluation of 5-aminoisoquinoline (5-AIQ), a novel PARP-1 inhibitor for genotoxicity potential in vitro and in vivo.

Journal: Toxicology mechanisms and methods20100201

Title: Antimycin A-induced cell death depends on AIF translocation through NO production and PARP activation and is not involved in ROS generation, cytochrome c release and caspase-3 activation in HL-60 cells.

Journal: The Journal of antibiotics20090301

Title: Possible role of poly(ADP-ribose) polymerase in pathological and physiological cardiac hypertrophy.

Journal: Methods and findings in experimental and clinical pharmacology20061201

Title: Using fragment cocktail crystallography to assist inhibitor design of Trypanosoma brucei nucleoside 2-deoxyribosyltransferase.

Journal: Journal of medicinal chemistry20061005

Title: Microsphere-based protease assays and screening application for lethal factor and factor Xa.

Journal: Cytometry. Part A : the journal of the International Society for Analytical Cytology20060501

Title: Poly(ADP-Ribose) polymerase inhibition reduces reperfusion injury after heart transplantation.

Journal: Circulation research20020111